Growth Metrics

Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020)

Damora Therapeutics posted quarterly Preferred Dividend Payments of $2.7 million for Q3 2020, up 93.65% year-on-year from $1.4 million in Q4 2019, and up 93.65% on a QoQ basis from $1.4 million in Q4 2019.

Damora Therapeutics (DMRA) has 2 years of Preferred Dividend Payments data on file, last reported at $2.7 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Damora Therapeutics 853.36 Mn 650.97 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 2.71 Mn
Dec 31, 2019 1.40 Mn
Sep 30, 2019 1.40 Mn